The miR-17-92 cluster functions to mitigate stemness and GEM resistance in pancreatic cancer stem cells by acting on the NODAL/ACTIVIN/TGF-b1 pathway [162]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.